The MAPK Pathway Is a Predominant Regulator of HLA-A Expression in Esophageal and Gastric Cancer

Journal of Immunology - United States
doi 10.4049/jimmunol.1301597
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

RN181 Is a Tumour Suppressor in Gastric Cancer by Regulation of the ERK/MAPK-cyclin D1/Cdk4 Pathway

Journal of Pathology
Forensic MedicinePathology
2019English

Transcription Factor CUTL1 Is a Negative Regulator of Drug Resistance in Gastric Cancer

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

The Expression of the PI3K/AKT/mTOR Pathway in Gastric Cancer and Its Role in Gastric Cancer Prognosis

OncoTargets and Therapy
OncologyPharmacology
2015English

A Positive Feedback Between IDO1 Metabolite and COL12A1 via MAPK Pathway to Promote Gastric Cancer Metastasis

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

Oncogenic AKAP9-BRAF Fusion Is a Novel Mechanism of MAPK Pathway Activation in Thyroid Cancer

Journal of Clinical Investigation
Medicine
2005English

A Case of Double Cancer of Multiple Esophageal Cancer and Multiple Gastric Cancer

Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
2007English

A Case of Early Gastric Cancer in the Reconstructed Gastric Tube After Radical Resection for Esophageal Cancer

The journal of the Japanese Practical Surgeon Society
1997English

Identification of PTPN1 as a Novel Negative Regulator of the JNK MAPK Pathway Using a Synthetic Screening for Pathway-Specific Phosphatases

Scientific Reports
Multidisciplinary
2017English

A Case of Scirrhous-Type Gastric Cancer in the Gastric Tube of a Patient Previously Treated for Thoracic Esophageal Cancer

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy